Literature DB >> 1894019

Late luteal estradiol patterns are a better prognosticator of pregnancy outcome than serial beta-human chorionic gonadotropin concentrations.

H C Liu1, O Davis, A Berkeley, M Graf, Z Rosenwaks.   

Abstract

OBJECTIVE: Since the corpus luteum (CL) is known to play an important role in early pregnancy, its activity could possibly be a marker for pregnancy outcome.
DESIGN: The late estradiol (E2) concentration in 48 viable pregnancies and 39 pregnancies which resulted in spontaneous abortions after in vitro fertilization and embryo transfer were used to evaluate such predictability.
SETTING: All patients studied were of the Center for Reproductive Medicine at Cornell University Medical College. PATIENTS, PARTICIPANTS: Eighty-seven patients.
INTERVENTIONS: None. MAIN OUTCOME MEASURE: Serum E2 and human chorionic gonadotropin (hCG) concentrations on day +11, +13, +15 (day +1 = day of ovum pick-up) were measured and studied.
RESULTS: The late luteal CL activity after rescue had a positive correlation with the number and quality of the implanted embryos. Reduced CL activity was indicative of abortion. The late luteal E2 pattern when compared with hCG doubling time had a better abortion predictability (37.8% versus 63.9%, respectively).
CONCLUSION: Corpus luteum activity demonstrated to be a better prognosticator of abortion than serial beta-hCG titers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894019     DOI: 10.1016/s0015-0282(16)54534-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

2.  Factors related to early pregnancy recognition in the woman.

Authors:  B Behr; B Stone; W D Foote
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

3.  Results from adding recombinant LH for assisted reproductive technology treatment: A randomized control trial.

Authors:  Mohammad-Hossein Razi; Fereshteh Mohseni; Razieh Dehghani Firouzabadi; Sima Janati; Nahid Yari; Sahabeh Etebary
Journal:  Iran J Reprod Med       Date:  2014-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.